roxifiban has been researched along with Sensitivity and Specificity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucher, RJ; Brockson, RW; Miyawa, JH; Williams, RC | 1 |
Billheimer, JT; Bradley, JD; Cromley, DA; Daly, RN; Dicker, IB; Godonis, HE; Gorko, MA; Grimminger, LC; He, B; Hollis, GF; Kieras, CJ; Pedicord, DL; Seiffert, D; Spitz, SM; Stern, AM; Thomas, BE; Wynn, R; Zolotarjova, NI | 1 |
2 other study(ies) available for roxifiban and Sensitivity and Specificity
Article | Year |
---|---|
Optimization and validation of chiral high-performance liquid chromatographic method for analysis of a fibrinogen (gpIIb/IIIa) receptor antagonist.
Topics: Amidines; Chromatography, High Pressure Liquid; Fibrinolytic Agents; Isoxazoles; Orosomucoid; Platelet Glycoprotein GPIIb-IIIa Complex; Quality Control; Sensitivity and Specificity; Stereoisomerism | 1999 |
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
Topics: Administration, Oral; Amidines; Animals; Antibodies; Biological Availability; Clinical Trials, Phase II as Topic; Enzyme-Linked Immunosorbent Assay; Epitopes; Humans; Isoxazoles; Kinetics; Pan troglodytes; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Sensitivity and Specificity; Thrombocytopenia | 2002 |